Jill Broadfoot | Chief Financial Officer and Principal Accounting Officer |
Sanjay Shukla | President and Chief Executive Officer |
Zegbeh Jallah | ROTH Capital Partners, LLC |
Joseph Pantginis | H.C. Wainwright & Co, LLC |
Hartaj Singh | Oppenheimer & Co. Inc. |
Ladies and gentlemen, thank you for standing by, and welcome to the aTyr Pharma Fourth Quarter and Full-Year 2019 Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker, Ms.